This article provides a review of various 2000-L single-use bioreactors used by biopharmaceutical suppliers for commercial production.
Several companies have invested in 2000-L single-use bioreactors to expand production capabilities, including Thermo Fisher Scientific, GE Healthcare, Pall Biotech, and Sartorius Stedim Biotech. This article highlights the features, functions, and capacities of several large-volume bioreactors by these companies that are used in the market today.
Read this article in BioPharm International's Single-Use Systems 2019 eBook.
BioPharm International
eBook: Single-Use Systems 2019
Vol. 32
June 2019
Pages: 24–27
When referring to this article, please cite it as A. Lowry, "Single-Use Bioreactors Unwrap Commercial Manufacturing Options," BioPharm International Single-Use Systems eBook (June 2019).
Thermo Fisher Opens Advanced Therapies Collaboration Center in California
April 18th 2025The 6000-square-foot facility will provide cell therapy developers the support they need to transition to CGMP manufacturing, and an expanded footprint of the new center is expected to open in Philadelphia later in 2025.